Use of tangeretin in cancer treatment

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9808439
APP PUB NO 20170027900A1
SERIAL NO

14848360

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses a pharmaceutical composition of treating multidrug resistance cancer, comprising a citrus methoxyflavone and a chemotherapeutic drug, in which the citrus methoxyflavone is tangeretin. A method of treating multidrug resistance cancer comprising administrating citrus methoxyflavone and a chemotherapeutic drug is also disclosed.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGYCHINESE MACAO TAIPA WEILONG ROAD MACAO MACAO

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Feng, Sen-ling Macau, CN 4 0
Liu, Liang Macau, CN 768 9740
Ma, Wen-zhe Macau, CN 3 0
Xie, Ying Macau, CN 75 721
Yao, Xiao-jun Macau, CN 10 23
Yuan, Zhong-wen Macau, CN 4 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 May 7, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 7, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00